Found 5 matching trials
Evaluation of 611 in Combination With Topical Corticosteroid in Participants With Moderate to Severe Atopic Dermatitis PHASE3 This is a randomized, double-blind, placebo-controlled, parallel-group stud...
Show More Status
Active Not Recruiting
Location
Shanghai Dermatology Hospital
Learn More & Join Trial
Evaluation of 611 in Chinese Children and Adolescents With Moderate to Severe Atopic Dermatitis PHASE1 The primary objective of the study was to evaluate the safety and pharmacok...
Show More Location
Beijing Children's Hospital
Learn More & Join Trial
Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis PHASE3 The primary objective of the study was to evaluate the efficacy of 611 in C...
Show More Location
Peking University People's Hospital
Learn More & Join Trial
Evaluation of 611 in Chinese Children With Moderate to Severe Atopic Dermatitis(AD) PHASE3 This study is a 2-part (parts A and B) study.The primary objective of the s...
Show More Location
Beijing Children's Hospital, Capital Medical University
Learn More & Join Trial
Evaluation of 611(Recombinant Humanized Anti-interleukin-4 Receptor Alpha IgG4 Monoclonal Antibody) in Chinese Adults With Moderate to Severe Atopic Dermatitis PHASE3 The primary objective of the study was to evaluate the efficacy of 611 in C...
Show More Location
Peking University People's Hospital
Learn More & Join Trial